M

Minoryx Therapeutics

32 employees

Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.

Basic info

Industry

biotechnology research

Sectors

Rare diseases
Biotechnology
X-linked Adrenoleukodystrophy
Neurometabolic diseases
Orphan CNS
Health Care
Genetics
Medical
Pharmaceutical
Friedreich's Ataxia

Date founded

2011

Funding rounds raised

Total raised

$55M

from 17 investors over 17 rounds

M

Minoryx Therapeutics raised $55M on May 31, 2022

Investors: COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U., Ysios Capital, FundPlus and CDTI, Centre for the Development of Industrial Technology

M

Minoryx Therapeutics raised $29M on October 30, 2020

Investors: European Investment Bank

M

Minoryx Therapeutics raised $5.1M on October 1, 2018

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

M

Minoryx Therapeutics raised $25M on September 26, 2018

Investors: SRIW, -, Chiesi Ventures, FundPlus, Ysios Capital and Idinvest Partners

M

Minoryx Therapeutics raised $22M on October 14, 2015

Investors: Chiesi Ventures, Idinvest Partners, Ysios Capital and Healthequity, SCR

M

Minoryx Therapeutics raised $808K on April 9, 2015

Investors: Healthequity, SCR

FAQ